Independent Advisor Alliance Sells 7,220 Shares of PetMed Express, Inc. (NASDAQ:PETS)

Independent Advisor Alliance cut its stake in shares of PetMed Express, Inc. (NASDAQ:PETSFree Report) by 25.0% in the 4th quarter, HoldingsChannel.com reports. The firm owned 21,671 shares of the company’s stock after selling 7,220 shares during the quarter. Independent Advisor Alliance’s holdings in PetMed Express were worth $104,000 as of its most recent SEC filing.

Separately, R Squared Ltd acquired a new position in PetMed Express during the fourth quarter valued at approximately $31,000. Hedge funds and other institutional investors own 73.33% of the company’s stock.

Analysts Set New Price Targets

Separately, StockNews.com cut PetMed Express from a “buy” rating to a “hold” rating in a report on Tuesday, February 11th.

Check Out Our Latest Research Report on PetMed Express

PetMed Express Stock Performance

PetMed Express stock opened at $4.04 on Friday. PetMed Express, Inc. has a 52 week low of $2.90 and a 52 week high of $6.85. The stock has a market capitalization of $83.45 million, a P/E ratio of 404.40 and a beta of 0.78. The stock has a 50-day simple moving average of $4.57 and a 200 day simple moving average of $4.48.

PetMed Express (NASDAQ:PETSGet Free Report) last posted its quarterly earnings results on Monday, February 10th. The company reported ($0.03) EPS for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.02). PetMed Express had a return on equity of 0.37% and a net margin of 0.14%. Research analysts forecast that PetMed Express, Inc. will post 0.19 earnings per share for the current year.

About PetMed Express

(Free Report)

PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.

Further Reading

Want to see what other hedge funds are holding PETS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for PetMed Express, Inc. (NASDAQ:PETSFree Report).

Institutional Ownership by Quarter for PetMed Express (NASDAQ:PETS)

Receive News & Ratings for PetMed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetMed Express and related companies with MarketBeat.com's FREE daily email newsletter.